Cassava Sciences
SAVA
#9274
Rank
S$0.14 B
Marketcap
S$3.03
Share price
12.26%
Change (1 day)
57.98%
Change (1 year)

Earnings for Cassava Sciences (SAVA)

Earnings in 2025 (TTM): -S$0.15 Billion

According to Cassava Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$0.19 Billion a decrease over its 2023 earnings that were of -S$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cassava Sciences from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.15 Billion-18.74%
2024 -S$0.19 Billion34.28%
2023 -S$0.14 Billion32.41%
2022 -S$0.11 Billion143.46%
2021 -S$41.86 Million383.92%
2020 -S$8.65 Million36.96%
2019 -S$6.32 Million-25.56%
2018 -S$8.49 Million-44.25%
2017 -S$15.22 Million-20.11%
2016 -S$19.05 Million5.32%
2015 -S$18.09 Million14.23%
2014 -S$15.84 Million-139.64%
2013 S$39.93 M
2010 -S$17.45 Million102.87%
2009 -S$8.6 Million-177.52%
2008 S$11.09 M-14.32%
2007 S$12.94 M-1942.21%
2006 -S$0.71 Million
2004 -S$49.61 Million75.1%
2003 -S$28.34 Million
2001 -S$22.05 Million20.49%
2000 -S$18.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.19 Billion 31.98%๐Ÿ‡บ๐Ÿ‡ธ USA